Artemisinins as potential anticancer agents: uptake detection in erythrocytes using Fourier transform infrared spectroscopy and cytotoxicity against bladder cancer cells
- PMID: 27153874
- DOI: 10.1136/jclinpath-2016-203721
Artemisinins as potential anticancer agents: uptake detection in erythrocytes using Fourier transform infrared spectroscopy and cytotoxicity against bladder cancer cells
Abstract
Aims: Semisynthetic derivatives of the antimalarial drug artemisinin may also possess anticancer properties. The ability to detect artemisinin uptake and distribution in cells would facilitate live cell imaging without labelling. This study describes mid-range infrared absorption spectra for three artemisinin variants and attempts to detect their presence in a simple cell model (erythrocytes). Cytotoxicity assays assess potential anticancer properties against bladder cancer cells.
Methods: Mid-range Fourier transform infrared spectra were obtained from dry preparations of dihydroartemisinin (DHA), artesunate (ART) and artemether (ARTE). Erythrocytes were prepared from normal blood and incubated for 30 min at 37°C with the three artemisinin derivatives. Cytospin preparations were prepared on aluminium foil for spectroscopy. Potential for growth inhibition in the RT112 bladder carcinoma cell line was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide residual viable biomass method.
Results: Spectra were obtained from the three native compounds. Repeat scans after 8 weeks showed ART and ARTE to be stable, stored under manufacturer's recommendations. DHA exhibited marked changes over the same period. It was possible by subtraction to detect DHA in cytospins, but not ART or ARTE. The fit between the subtraction spectrum and that of the native compound was >80%. DHA and ART showed strong cytotoxic potential against RT112 cells.
Conclusions: The artemisinin derivatives tested exhibit unique mid-range infrared absorption spectra which can be used to monitor degradation and, for DHA, can be detected by subtraction in loaded erythrocytes rendering future imaging studies feasible. Its cytotoxic efficacy against RT112 cells suggests bladder cancer as a possible target disease.
Keywords: ANALYTICAL METHODS; BLADDER; CANCER; CELL BIOLOGY; ERYTHROCYTE.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
-
Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest.Acta Biochim Biophys Sin (Shanghai). 2018 Dec 1;50(12):1227-1235. doi: 10.1093/abbs/gmy125. Acta Biochim Biophys Sin (Shanghai). 2018. PMID: 30395153
-
Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.Int J Pharm. 2014 Jun 5;467(1-2):113-22. doi: 10.1016/j.ijpharm.2014.03.044. Epub 2014 Mar 22. Int J Pharm. 2014. PMID: 24661944
-
Fourier Transform Infrared Spectroscopy Monitoring of Dihydroartemisinin-Induced Growth Inhibition in Ovarian Cancer Cells and Normal Ovarian Surface Epithelial Cells.Cancer Manag Res. 2020 Jan 29;12:653-661. doi: 10.2147/CMAR.S240285. eCollection 2020. Cancer Manag Res. 2020. PMID: 32099462 Free PMC article.
-
Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.PLoS One. 2017 Feb 9;12(2):e0171840. doi: 10.1371/journal.pone.0171840. eCollection 2017. PLoS One. 2017. PMID: 28182780 Free PMC article.
-
Anticancer Activity of Artemisinin and its Derivatives.Anticancer Res. 2017 Nov;37(11):5995-6003. doi: 10.21873/anticanres.12046. Anticancer Res. 2017. PMID: 29061778 Review.
Cited by
-
Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer.Med Sci (Basel). 2018 Feb 27;6(1):19. doi: 10.3390/medsci6010019. Med Sci (Basel). 2018. PMID: 29495461 Free PMC article. Review.
-
Dihydroartemisinin Induces Apoptosis in Human Bladder Cancer Cell Lines Through Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cytochrome C Pathway.Int J Prev Med. 2017 Oct 5;8:78. doi: 10.4103/ijpvm.IJPVM_258_17. eCollection 2017. Int J Prev Med. 2017. PMID: 29114376 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources